Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avenue Therapeutics, Inc. (ATXI) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avenue Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1644963.
Total stock buying since 2017: $1,170,641.
Total stock sales since 2017: $3,172,058.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 500 | $1,249 | 84 | $182 | 0 | $0 |
| 2023 | 767,085 | $552,301 | 617,000 | $87,613 | 0 | $0 |
| 2022 | 0 | $0 | 388,888 | $2,999,882 | 0 | $0 |
| 2021 | 2,500 | $9,975 | 7,160 | $11,599 | 0 | $0 |
| 2020 | 17,150 | $152,061 | 3,840 | $46,579 | 0 | $0 |
| 2019 | 48,500 | $286,543 | 4,688 | $26,203 | 0 | $0 |
| 2018 | 21,234 | $105,065 | 0 | $0 | 0 | $0 |
| 2017 | 11,500 | $63,447 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 0 | $0 | 23 | $46 | 0 | $0 |
| 2024-11 | 0 | $0 | 61 | $136 | 0 | $0 |
| 2024-09 | 500 | $1,249 | 0 | $0 | 0 | $0 |
| 2023-12 | 0 | $0 | 617,000 | $87,613 | 0 | $0 |
| 2023-09 | 767,085 | $552,301 | 0 | $0 | 0 | $0 |
| 2022-10 | 0 | $0 | 388,888 | $2,999,882 | 0 | $0 |
| 2021-09 | 0 | $0 | 7,160 | $11,599 | 0 | $0 |
| 2021-05 | 2,500 | $9,975 | 0 | $0 | 0 | $0 |
| 2020-08 | 0 | $0 | 3,840 | $46,579 | 0 | $0 |
| 2020-03 | 3,389 | $26,968 | 0 | $0 | 0 | $0 |
| 2020-02 | 13,761 | $125,093 | 0 | $0 | 0 | $0 |
| 2019-09 | 16,000 | $100,320 | 0 | $0 | 0 | $0 |
| 2019-08 | 0 | $0 | 4,688 | $26,203 | 0 | $0 |
| 2019-06 | 5,000 | $29,300 | 0 | $0 | 0 | $0 |
| 2019-04 | 1,000 | $4,520 | 0 | $0 | 0 | $0 |
| 2019-03 | 2,000 | $10,220 | 0 | $0 | 0 | $0 |
| 2019-02 | 13,850 | $79,344 | 0 | $0 | 0 | $0 |
| 2019-01 | 10,650 | $62,839 | 0 | $0 | 0 | $0 |
| 2018-12 | 15,000 | $78,550 | 0 | $0 | 0 | $0 |
| 2018-06 | 5,234 | $22,715 | 0 | $0 | 0 | $0 |
| 2018-04 | 1,000 | $3,800 | 0 | $0 | 0 | $0 |
| 2017-10 | 11,500 | $63,447 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-02 | Herskowitz Neil | Sale | 23 | 2.00 | 46 |
| 2024-11-05 | Kranzler Jay D | Sale | 61 | 2.24 | 136 |
| 2024-09-30 | Kranzler Jay D | Buy | 497 | 2.50 | 1,242 |
| 2024-09-27 | Kranzler Jay D | Buy | 3 | 2.40 | 7 |
| 2023-12-11 | Davidow Robert L | Sale | 617,000 | .14 | 87,613 |
| 2023-09-08 | Fortress Biotech, Inc. (10% Owner) | Buy | 418,410 | .72 | 301,255 |
| 2023-09-08 | Rosenwald Lindsay A Md (Director) | Buy | 348,675 | .72 | 251,046 |
| 2022-10-11 | Invagen Pharmaceuticals, Inc. | Sale | 388,888 | 7.71 | 2,999,882 |
| 2021-09-15 | Vazzano Joseph Walter (Chief Financial Officer) | Sale | 7,160 | 1.62 | 11,599 |
| 2021-05-06 | Herskowitz Neil | Buy | 2,500 | 3.99 | 9,975 |
| 2020-08-20 | Vazzano Joseph Walter (Chief Financial Officer) | Sale | 3,840 | 12.13 | 46,579 |
| 2020-03-10 | Vazzano Joseph Walter (Chief Financial Officer) | Buy | 1,889 | 7.94 | 14,998 |
| 2020-03-09 | Vazzano Joseph Walter (Chief Financial Officer) | Buy | 1,500 | 7.98 | 11,970 |
| 2020-02-27 | Herskowitz Neil | Buy | 2,400 | 8.20 | 19,680 |
| 2020-02-26 | Herskowitz Neil | Buy | 161 | 8.73 | 1,405 |
| 2020-02-25 | Vazzano Joseph Walter (Chief Financial Officer) | Buy | 1,200 | 9.09 | 10,908 |
| 2020-02-25 | Herskowitz Neil | Buy | 10,000 | 9.31 | 93,100 |
| 2019-09-12 | Ingram Elizabeth Garrett | Buy | 16,000 | 6.27 | 100,320 |
| 2019-08-09 | Vazzano Joseph Walter (Chief Financial Officer) | Sale | 2,375 | 5.56 | 13,204 |
| 2019-08-08 | Vazzano Joseph Walter (Chief Financial Officer) | Sale | 2,313 | 5.62 | 12,999 |
| 2019-06-18 | Herskowitz Neil | Buy | 2,000 | 5.83 | 11,660 |
| 2019-06-17 | Herskowitz Neil | Buy | 3,000 | 5.88 | 17,640 |
| 2019-04-15 | Herskowitz Neil | Buy | 1,000 | 4.52 | 4,520 |
| 2019-03-29 | Herskowitz Neil | Buy | 1,400 | 5.11 | 7,154 |
| 2019-03-28 | Herskowitz Neil | Buy | 600 | 5.11 | 3,066 |
| 2019-02-25 | Herskowitz Neil | Buy | 5,000 | 5.46 | 27,300 |
| 2019-02-05 | Herskowitz Neil | Buy | 1,850 | 5.77 | 10,674 |
| 2019-02-04 | Herskowitz Neil | Buy | 7,000 | 5.91 | 41,370 |
| 2019-01-30 | Herskowitz Neil | Buy | 650 | 5.91 | 3,841 |
| 2019-01-29 | Herskowitz Neil | Buy | 8,553 | 5.91 | 50,548 |
| 2019-01-28 | Herskowitz Neil | Buy | 1,447 | 5.84 | 8,450 |
| 2018-12-10 | Paley Jeffrey | Buy | 5,000 | 4.76 | 23,800 |
| 2018-12-03 | Paley Jeffrey | Buy | 10,000 | 5.47 | 54,750 |
| 2018-06-08 | Rosenwald Lindsay A Md | Buy | 5,234 | 4.34 | 22,715 |
| 2018-04-25 | Herskowitz Neil | Buy | 1,000 | 3.80 | 3,800 |
| 2017-10-17 | Herskowitz Neil | Buy | 1,000 | 5.01 | 5,010 |
| 2017-10-09 | Herskowitz Neil | Buy | 500 | 5.24 | 2,620 |
| 2017-10-09 | Rosenwald Lindsay A Md | Buy | 1,350 | 5.40 | 7,290 |
| 2017-10-06 | Rosenwald Lindsay A Md | Buy | 2,900 | 5.63 | 16,327 |
| 2017-10-05 | Rosenwald Lindsay A Md | Buy | 3,550 | 5.60 | 19,880 |
| 2017-10-04 | Rosenwald Lindsay A Md | Buy | 2,200 | 5.60 | 12,320 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avenue Therapeutics, Inc. (symbol ATXI, CIK number 1644963) see the Securities and Exchange Commission (SEC) website.